Arcutis Biotherapeutics, Inc. (ARQT)
26.97
-1.60
(-5.60%)
USD |
NASDAQ |
Feb 27, 16:00
26.97
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Research and Development Expense (TTM) : 77.05M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CorMedix, Inc. | 12.46M |
| ADMA Biologics, Inc. | 4.761M |
| ANI Pharmaceuticals, Inc. | -- |
| Amicus Therapeutics, Inc. | 135.84M |
| Mirum Pharmaceuticals, Inc. | 185.83M |